
Expert Directory
Joel M. Gelfand, MD, MSCE
James J. Leyden, MD Professor of Clinical Investigation
Professor of Dermatology and Epidemiology
Perelman School of Medicine
University of Pennsylvania
Philadelphia, PA
Joel M. Gelfand, MD, MSCE,, is the James J. Leyden, MD Professor of Clinical Investigation, professor (with tenure) of dermatology and epidemiology, director (cofounding) of the Center for Clinical Sciences in Dermatology, and director of the Psoriasis and Phototherapy Treatment Center at the University of Pennsylvania Perelman School of Medicine.
Dr Gelfand is an internationally recognized expert in psoriasis, epidemiology, drug safety, and clinical trials. He is the author of more than 330 scientific publications cited more than 40,000 times (h-index 100).
His research program was the first to establish that psoriasis patients have an increased risk of cardiovascular disease and mortality. He conducts patient-centered research through the Dermatology Clinical Effectiveness Research Network (DCERN), which he founded in 2009 and involves more than 50 dermatology sites in the United States. He has received investigator-initiated research grants from the National Institutes of Health, the US Food and Drug Administration, the Patient-Centered Outcomes Research Institute (PCORI), foundations, and industry.
Dr Gelfand has given more than 10 named lectureships and keynote addresses, including the Society for Investigative Dermatology Eugene M. Farber Lecture and the American Academy of Dermatology Marion B. Sulzberger, MD, Lectureship. He is the recipient of numerous awards, including the American College of Epidemiology 2023 Outstanding Contributions Award, the American Skin Association Psoriasis Achievement Award, the Lady Barbara Colyton Prize for Autoimmune Research, the National Psoriasis Foundation Scientific Achievement Award, and the American DermatoEpidemiology Network Founders Award. He is an elected member of the American Society for Clinical Investigation. He is a member of the Board of Directors for the International Psoriasis Council and the Medical Dermatology Society.
Contributing Articles


New Treatment Options for the Management of Palmoplantar Pustulosis

Conference Reporter in Plaque Psoriasis to Cover Key Topics Being Presented at the Fall Clinical Dermatology Conference 2024

Evidence-Based Medicine on Laboratory Monitoring for Biologics

Best Biologic Choices After Therapeutic Failure on a Biologic
